Skip to main content
SpringerLink
Log in

Biochemical control of breast aromatase

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Aromatase activity is increased in breast tumors and it is possible that this results from stimulation by cytokines and/or prostaglandin E2 (PGE2) which regulate the activity of this enzyme. As different promoters can be used to control aromatase gene expression in normal and malignant breast tissues, which are regulated by different factors, we are currently investigating the relative roles of cytokines and PGE2 in controlling breast tumor aromatase activity. No significant effect of PGE2 on aromatase activity in MCF-7 breast cancer cells has so far been detected. However, preliminary evidence was obtained, from co-cultures of MCF-7 cells and breast tumor-derived fibroblasts, that MCF-7 cells secrete a factor, possibly a cytokine, which can act in a paracrine manner to enhance aromatase activity in stromal cells. Understanding the complex regulation of aromatase activity in breast tumors could lead to novel therapies for specifically inhibiting tumor estrogen synthesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bonney RC, Reed MJ, Davidson K, Beranek P, James VHT: The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol 19: 727–739, 1983

    CAS  Google Scholar 

  2. Van Landeghem AJJ, Poortman J, Nabuurs M, Thijssen JHH: Endogenous concentrations and subcelluar distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45: 2900–2906, 1985

    PubMed  CAS  Google Scholar 

  3. Vermeulen A, Deslypere JP, Paridaens R, Leclerq G, Roy F, Henson JC: Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer 22: 515–525, 1986

    Article  CAS  Google Scholar 

  4. Miller WR, Forrest APM: Oestradiol synthesis from C19 steroids by human breast cancer. Br J Cancer 33: 16–18, 1974

    Google Scholar 

  5. James VHT, McNeil JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ: Aromatase activity in normal breast and breast tumour tissue: in vivo and in vitro studies. Steroids 50: 269–279, 1987

    Article  PubMed  CAS  Google Scholar 

  6. Bradlow HL: A reassessment of the role of breast tumor aromatase. Cancer Res 42(Suppl): 3382s–3386s, 1982

    PubMed  CAS  Google Scholar 

  7. Reed MJ: The role of aromatase in breast cancer. Br Cancer Res Treat 30: 7–17, 1994

    Article  CAS  Google Scholar 

  8. Reed MJ, Owen AM, Lai LC, Coldham NG, Shaikh NA, James VHT: In situ oestrone synthesis in normal breast and breast tumour tissue: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44: 233–237, 1989

    PubMed  CAS  Google Scholar 

  9. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A: Expression of aromatase protein and mRNA in tumour epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancer. Endocrinology 137: 3061–3068, 1996

    Article  PubMed  CAS  Google Scholar 

  10. Mahendroo MS, Mendelson CR, Simpson ER: Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 268: 19463–19470, 1993

    PubMed  CAS  Google Scholar 

  11. Harada N, Utsumi T, Takagi T: Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in careniogenesis. Proc Natl Acad Sci USA 90: 11312–11316, 1993

    Article  PubMed  CAS  Google Scholar 

  12. Utsumi T, Harada N, Maruta M, Takagi Y: Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab 81: 2344–2349, 1996

    Article  PubMed  CAS  Google Scholar 

  13. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER: Use of alternative promoters to express the aromatase cytochrome P450 (Cyp 19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 81: 3843–3849, 1996

    Article  PubMed  CAS  Google Scholar 

  14. Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER: Aromatase P-450 gene expression in human adipose tissue: a role of Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 270: 16449–16457, 1995

    Article  PubMed  CAS  Google Scholar 

  15. Schrey MP, Patel KV: Prostaglandin E2 production and metabelism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer 72: 1412–1419, 1995

    PubMed  CAS  Google Scholar 

  16. Zhao Y, Agarwal VR, Mendelson CR, Simpson ER: Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP 19 (aromatase) gene. Endocrinology 137: 5739–5742, 1996

    Article  PubMed  CAS  Google Scholar 

  17. Singh A, Reed MJ: Insulin-like growth factor I and insulin-like growth factor II stimulate oestradiol 17β-hydroxysteroid dehydrogenase activity in breast cancer cells. J Endocrinol 129: R5–R8, 1991

    PubMed  Google Scholar 

  18. Newton CJ, Samuel DL, James VHT: Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal tissue. J Steroid Biochem 24: 1033–1039, 1986

    Article  PubMed  CAS  Google Scholar 

  19. Macdiarmid F, Wang D, Duncan LJ, Purohit A, Ghilchik MW, Reed MJ: Stimulation of aromatase activity in breast fibroblasts by tumour necrosis factor α. Mol Cell Endocrinol 106: 17–21, 1994

    Article  PubMed  CAS  Google Scholar 

  20. Reed MJ, Coldham NG, Patel SR, Ghilchik MW, James VHT: Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. J Endocrinol 132: R5–R8, 1992

    Article  PubMed  Google Scholar 

  21. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, Reed MJ: Aromatase activity in interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 80: 3052–3058, 1995

    Article  PubMed  CAS  Google Scholar 

  22. Singh A, Purohit A, Duncan LJ, Mokbel K, Ghilchik MW, Reed MJ: Control of aromatase activity in breast tumours: the role of the immune system. J Steroid Biochem Mol Biol 61: 185–192, 1997

    Article  PubMed  CAS  Google Scholar 

  23. O'Nell JS, Elton RA, Miller WR: Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br Med J 296: 741–743, 1988

    Article  Google Scholar 

  24. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER: A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77: 1622–1628, 1993

    Article  PubMed  CAS  Google Scholar 

  25. Reed MJ, Topping L, Coldham NG, Purohit A, Ghilchik MW, Reed MJ, James VHT: Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J Steroid Biochem Mol Biol 44: 1033–1039, 1993

    Article  Google Scholar 

  26. Matovani G, Maccio A, Esu S, Lai P, Santona MC, Massa E, Dessi D, Melis GB, Del Giacco GS: Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur J Cancer 33: 602–607, 1997

    Article  Google Scholar 

  27. Guthrie GP, John WJ: The in vivo glucocorticoid and anti-glucocorticoid actions of medroxyprogesterone acetate. Endocrinology 107: 1393–1396, 1980

    Article  PubMed  CAS  Google Scholar 

  28. Yamashita J-I, Hideshima T, Shirakusa T, Ogawa M: Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma. Cancer 78: 2346–2353, 1996

    Article  PubMed  CAS  Google Scholar 

  29. Lundgren S, Helle SI, Lonning PE: Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients. Clin Cancer Res 2: 1515–1521, 1996

    PubMed  CAS  Google Scholar 

  30. Siiteri PK, MacDonald PC: Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB (eds) Handbook of Physiology. Am Physiol Soc. Washington DC, Vol II, part I, 1973, pp 615–629

    Google Scholar 

  31. Wei J, Xu H, Davies JL, Hemmings GP: Increase of plasma IL-6 concentrations with age in healthy subjects. Life Sci 51: 1953–1956, 1992

    Article  PubMed  CAS  Google Scholar 

  32. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y: Altered regulation of IL-6 production with normal aging. J Immunol 150: 5219–5230, 1993

    PubMed  CAS  Google Scholar 

  33. Hotamisligil GS, Shargill NS, Spiegleman BM: Adipose expression of tumor necrosis factor α: a direct role in obesity linked insulin resistance. Science 259: 87–91, 1993

    PubMed  CAS  Google Scholar 

  34. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegleman BM: Increased adipose tissue expression of tumor necrosis factor α in human obesity and insulin resistance. J Clin Invest 95: 2409–2415, 1995

    Article  PubMed  CAS  Google Scholar 

  35. Reed MJ: The discriminant function test: a marker of Th1/Th2 cytokine secretion and breast tumour oestrogen synthesis. Mol Med Today 1: 98–103, 1995

    Article  CAS  PubMed  Google Scholar 

  36. Larralde C, Morales J, Terrazas I, Govezensky T, Romano MC: Sex hormone changes induced by the parasite lead to feminization of the male host in murine Taenia crassiceps cysticercosis. J Steroid Biochem Mol Biol 52: 575–580, 1995

    Article  PubMed  CAS  Google Scholar 

  37. Maroles J, Larralde C, Cerbon MA, Rodriguez M, Romano MC: Participation of P450 aromatase and the immune system in the feminization process of the male host chronically infected with Taenia crassiceps cysticerci. Proc 13th Int Symposium of J Steroid Biochem Mol Biol Abstract 190-P. 1997

  38. Snijdewint FGM, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML: Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150: 5321–5329, 1993

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Purohit
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N.G. Coldham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M.W. Ghilchik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M.J. Reed
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, A., Purohit, A., Coldham, N. et al. Biochemical control of breast aromatase. Breast Cancer Res Treat 49 (Suppl 1), S9–S14 (1998). https://doi.org/10.1023/A:1006019917108

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006019917108

Search

Navigation